highly significantp < 0.001
While the pre-versus-post comparison of primary and secondary outcomes of the control group (received immunosuppressive therapies only) did not show a significant improvement ( p > 0.05), the same comparison within the weight-loss group showed a highly significant improvement in primary and secondary outcomes ( p < 0.001).